Novartis Korea Executives Indicted for Bribing Doctors

Mary Jane Wilmoth

Published On: August 10th, 2016

August 9, 2016. Pharmalot reports that six former and current Novartis executives at its Korean unit were indicted Monday on charges of paying doctors in return for prescribing its medicines. Read the full article.

Latest News & Insights

January 24, 2017
President Obama’s Whistleblower Legacy (Part Three)
January 23, 2017
SEC Protects Access to Whistleblower Rewards
January 17, 2017
President Obama’s Whistleblower Legacy (Part Two)
January 13, 2017
President Obama’s Whistleblower Legacy (Part One)

New Release

Rules for Whistleblowers

The ultimate guide to blowing the whistle and getting rewarded for doing what's right.

Order Your Copy

Subscribe for News & Resources

Receive exclusive updates and news from our firm.

Courageous Spanish Whistleblower Roberto Macías Becomes the First to Test the EU’s Pledge to Protect Whistleblowers

Will the SEC’s Proposed Whistleblower Rules Undermine the Deterrent Effect of the Dodd Frank Act?

The SEC Cannot Abandon Its Rules Protecting Internal Whistleblowers

Novartis Korea Executives Indicted for Bribing Doctors

Latest News & Insights

Rules for Whistleblowers

Subscribe for News & Resources

Subscribe to our newsletter to receive whistleblower news and resources crafted by the partners and associates at KKC.